You are receiving this email as a subscriber to Pharmaceutical Executive |
| |
 |
|
Have You Seen PharmExec.com's New and Improved Site Design?
» Visit www.pharmexec.com to utilize our upgraded search engine, view expanded topic coverage, experience multimedia content, access content archives, and more.
Interested in Learning About Other Topics?
Give us your ideas for a Future Webcast or Podcast |
| |
| Featured Webcasts: |
Tuesday, April 13, 2010 at 11:00 AM PT; 2:00 PM ET; 16:00 GMT
SaaS or On-premise CRM - It's Your Choice... Not Your Vendor's
As the life sciences industry continues to grow in complexity, its commercial model is changing too. The traditional ?single message to many? approach to delivering your product information has been re-focused to building and maintaining relationships to achieve lasting share of mind. Given the imperative to ?do more with less? your commercial organization may be re-evaluating the effectiveness of your Customer Relationship Management (CRM) system. What are the questions that you should be asking yourself and your vendor when considering a CRM investment? Please join us for a free live webcast, featuring a panel of industry experts who will share practical insights to help you define your organization?s current and future needs and determine what CRM capabilities are best suited meet them.
|
| » Register Free! |
|
|
Tuesday, April 20, 2010 at 11:00 AM ET; 8:00 AM PT
The Future of Commercial Models in Pharma
Today, many pharmaceutical executives are asking: How will we compete in a marketplace that, by 2015, will be 80% undifferentiated? What industry imperatives do we need to address in the design and implementation of our new commercial model? What does our organization need to do now in order to compete? Get the answers to these questions and more at the April 20 webcast, "The Future of Commercial Models in Pharma," where you?ll hear IMS experts describe how your organization needs to align with the market and organize for the future in order to design, and implement, the most efficient and effective commercial model.
|
| » Register Free! |
|
|
ON DEMAND
The Visibility Solution: Delivering an Accurate View of Clinical Operations
This is the second webinar for Kalido promoting its solutions for the Pharmaceutical industry. This event focuses on our Clinical Trials solution with HighPoint Solutions and is designed to illustrate how pharma companies can reduce the risk and expense of the clinical trial process with better use of data. Attend this Web seminar to understand how pharmaceutical manufacturers can obtain a clear and consistent view of clinical-trial progress and costs through effective data governance – providing a platform for future growth.
|
|
ON DEMAND
Maximizing Return on Information: A Google Case Study
Effective management of the R&D innovation cycle is critical to the long-term profitability of pharmaceutical and life sciences companies. Yet for most organizations, the process takes too long; according to the Pharmaceutical and Research Manufacturers of America (PhRMA), the average time from discovery and development to final market authorization for a new drug can take 12 to 15 years, leaving only 5 to 8 years of effective patent protection. Increasing the pace of innovation to commercialization has thus become a high priority for the entire life sciences industry. » More
|
| » Register Free! |
|
|
ON DEMAND
The New Landscape for Compliance with Medical Speaker Programs
This webcast will address recent developments and current trends in the regulation of medical speaker programs. It will review state-by-state changes in regulations, pending changes at the state and federal level, and trends among healthcare providers and associations to limit speaker program participation. Two leading experts in the field will provide practical advice on how to reposition speaker programs to align with new regulations and perceptions in healthcare. The potential impact of the Physicians Payment Sunshine Act and other measures towards greater transparency will be discussed. Alternatives to traditional venue-based programs, including the use of virtual media programs such as live web conferencing, will be evaluated. The webcast will conclude by reviewing best practices in the conduct of effective and compliant speaker programs.
|
| » Register Free! |
|
|
|
|
Data Governance: Business Data You Can Believe In
Bad data – and a lack of good data management practices – can cost your business millions of dollars every year. You have to treat your data like every other valuable asset in your business: You must protect it, nurture it and ensure that, like any asset, it’s in the best condition possible.
|
| » View Whitepaper |
|
Proven Reliability in Temperature Controlled Shipping
If you think all temperature-controlled solutions are the same, think again.
American Airlines Cargo has implemented a high-visibility, multi-layered system for temperature-controlled shipping that has gained accreditation in 60 cities in 24 countries worldwide. American's ExpediteTC solution delivers the kind of specialized air cargo expertise demanded by pharmaceutical customers and their freight forwarders.
A new marketing white paper from American Airlines Cargo covers special handling considerations which are designed to build confidence in the end-to-end shipping process for temperature-controlled pharmaceutical shipments.
American Airlines Cargo has certified, trained personnel in place worldwide to help overcome the challenges of delivering temperature-sensitive products cost-effectively and reliably. To gain a firm understanding of American's shipping solutions for the pharmaceutical industry, please download this valuable white paper.
|
| » View Whitepaper |
|
|
|
|
|
| Featured Content: |
Industry Audit 2009
Cast against a backdrop of global recession and pressure on the business model that is blurring the traditional strategic divide between generic and originator products, St. Joseph's University Professor Bill Trombetta presents our Eighth Annual Pharma Industry Audit, which this year digs deeper into current business trends by adding 11 new companies to the survey.
|
|
Pharm Exec 50
We leap tall buildings to bring you the definitive guide to the world's leading pharma companies...The world's top 50 pharmaceutical companies accounted for prescription drug sales of $558 billion in 2008. Though a few more companies dipped into negative growth than last year, more than half of the list achieved double-digit growth, a sign that although recession eventually hits even pharma, it usually hits later than in many other industries. Who's in, who's back, and who's out?
| » More... |
|
|
2009's Emerging Leaders
What will the drug industry look like in 20 years? Can we get there? How? The faces of innovation…Meet 27 industry pioneers under age 45 who are bringing new ideas to life.
|
| » More…. |
|
|
|
|
|
B2M Productions/Getty Images
|
|
|
|
